Tecan appoints Erik Norström Head of Corporate Development
(Thomson Reuters ONE) -
Tecan Group AG /
Tecan appoints Erik Norström Head of Corporate Development
. Processed and transmitted by Nasdaq Corporate Solutions.
The issuer is solely responsible for the content of this announcement.
Männedorf, Switzerland, June 2, 2017 - The Tecan Group (SIX Swiss Exchange:
TECN) announced today that Erik Norström has been appointed Head of Corporate
Development and a member of the Management Board. He will assume his new
position at Tecan no later than December 1, 2017.
Erik Norström held a number of Corporate Development and M&A positions with
increasing management responsibility in the broader healthcare and medical
technology industries. Since August 2015, he serves as Corporate Vice President,
Business Development at Chr. Hansen Holding A/S, Denmark (NASDAQ Copenhagen:
CHR), a global bioscience company that develops natural ingredient solutions for
the food, nutritional, pharmaceutical and agricultural industries. From 2012 to
2015, Erik Norström was Head of Business Development and M&A at Nobel Biocare
AG, Zürich, where he was responsible for the full range of business development
and M&A activities, including corporate strategy. Prior to this, he was Head of
M&A and Alliances at Nobel Biocare AG, Zürich (2008-2012), and before that he
served as Corporate Development Director at F. Hoffmann-La Roche AG, Basel
(2001-2008).
Erik Norström holds a Master degree in Chemical Engineering (Chalmers University
of Technology, Göteborg, Sweden) and a Bachelor degree in Business
Administration with a specialization in Financial Management (Göteborg
University of Economics, Sweden). Erik Norström is 43 years old and a Swedish
and Swiss citizen.
About Tecan
Tecan (www.tecan.com) is a leading global provider of laboratory instruments and
solutions in biopharmaceuticals, forensics and clinical diagnostics. The company
specializes in the development, production and distribution of automated
workflow solutions for laboratories in the life sciences sector. Its clients
include pharmaceutical and biotechnology companies, university research
departments, forensic and diagnostic laboratories. As an original equipment
manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM
instruments and components that are then distributed by partner companies.
Founded in Switzerland in 1980, the company has manufacturing, research and
development sites in both Europe and North America and maintains a sales and
service network in 52 countries. In 2016, Tecan generated sales of CHF 506
million (USD 511 million; EUR 464 million). Registered shares of Tecan Group are
traded on the SIX Swiss Exchange (TECN; ISIN CH0012100191).
For further information:
Tecan Group
Martin Braendle
Vice President, Communications & Investor Relations
Tel. +41 (0) 44 922 84 30
Fax +41 (0) 44 922 88 89
investor(at)tecan.com
www.tecan.com
Press Release:
http://hugin.info/100384/R/2110040/801876.pdf
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Tecan Group AG via GlobeNewswire
Unternehmensinformation / Kurzprofil:
Datum: 02.06.2017 - 07:25 Uhr
Sprache: Deutsch
News-ID 545965
Anzahl Zeichen: 3658
contact information:
Town:
Maennedorf
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 268 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Tecan appoints Erik Norström Head of Corporate Development"
steht unter der journalistisch-redaktionellen Verantwortung von
Tecan Group AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
